Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics ; volume:20 ; number:1 ; day:28 ; month:1 ; year:2020 ; pages:1-11 ; date:12.2020
Cancer cell international ; 20, Heft 1 (28.1.2020), 1-11, 12.2020
- Creator
-
Zweiri, Jehad
Christmas, Stephen E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-020-1115-4
- URN
-
urn:nbn:de:101:1-2020042703384607137653
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zweiri, Jehad
- Christmas, Stephen E.
- SpringerLink (Online service)
Other Objects (12)
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Glutarate regulates T cell metabolism and anti-tumour immunity
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Glutarate regulates T cell metabolism and anti-tumour immunity
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Glutarate regulates T cell metabolism and anti-tumour immunity
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody